[Novel actions of calcium channel blockers].
Kumagai
Hiroo
H
Department of Nephrology and Hypertension, Keio University School of Medicine.
Onami
Toshiko
T
Takimoto
Chie
C
Iigaya
Kamon
K
Hayashi
Koichi
K
D017311:Amlodipine / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001383:Azetidinecarboxylic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D003863:Depression; D004095:Dihydropyridines / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy; D011507:Proteinuria / Q000188:drug therapy; D013564:Sympathetic Nervous System / Q000187:drug effects
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D017311:Amlodipine; C061004:benidipine; D001383:Azetidinecarboxylic Acid; C061679:azelnidipine